SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-18-055828
Filing Date
2018-09-07
Accepted
2018-09-07 17:15:26
Documents
4
Period of Report
2018-09-07

Document Format Files

Seq Description Document Type Size
1 6-K a18-26023_46k.htm 6-K 25881
2 EX-1.1 a18-26023_4ex1d1.htm EX-1.1 277176
3 EX-5.1 a18-26023_4ex5d1.htm EX-5.1 47981
4 EX-99.1 a18-26023_4ex99d1.htm EX-99.1 9646
  Complete submission text file 0001104659-18-055828.txt   361712
Mailing Address DARWINWEG 24 LEIDEN P7 2333CR
Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 181060808
SIC: 2834 Pharmaceutical Preparations